Project Grant R21CA287170
Award Date
7/1/24
Completion Date
6/30/26
Dollars Obligated
$395K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
New Jersey, USA
Similar Awards
The National Institutes of Health (NIH) awarded a $675,599 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to Rutgers, The State University of New Jersey to study the "Implementation, Reach, and Impact of Court-Ordered Tobacco Corrective Statement Postings at the Point-of-Sale." This project aims to characterize the implementation and reach of court-mandated tobacco corrective statements that must be displayed in over 200,000 retail stores nationwide from...
This $129,708 Project Grant award from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) will support a 5-year study at Purdue University to examine the impact of local tobacco retail policies on sociodemographic disparities in tobacco use outcomes.
The key objectives of the study are to: 1) Describe and examine the impact of local tobacco retailer licensing laws and fees on differences in retailer density by race/ethnicity, income, and education; 2) Measure the...
This federal Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) provides $371,822 to Rutgers, The State University of New Jersey to conduct a series of studies on the impact of cigar package size on cigar use behaviors.
The key products and services to be delivered under this 5-year award include: 1) characterizing changes in cigar pack size over time and assessing its impact on sales, consumption, and patterns of...
This $171,742 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) supports research at Rutgers, The State University of New Jersey to address misperceptions that prevent adult smokers from completely switching to e-cigarettes.
The key objectives are to: 1) identify belief patterns about the harms of cigarettes versus e-cigarettes, 2) develop and refine...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research (CFDA 93.393) program, will provide $885,824 to Health Research, Inc. at Roswell Park in Buffalo, NY from August 1, 2024 to July 31, 2026. The award will fund a research study to explore consumer responses to the FDA's recent authorizations allowing smokeless tobacco products to make modified risk claims in advertising. Specifically, the study will investigate 1) consumer exposure...
This federal Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 Minority Health and Health Disparities Research program) provides $694,771 to the Regents of the University of Minnesota to evaluate population-based strategies for improving smoking cessation rates among rural populations.
The key objectives are to determine the efficacy of providing rural people who smoke with a free nicotine replacement therapy (NRT) starter kit and digital...
The National Institute on Drug Abuse (NIDA) awarded a $1,973,823 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to the Medical University of South Carolina (MUSC) to evaluate a tobacco harm reduction strategy among clients enrolled in substance use disorder (SUD) treatment. The study will compare the efficacy of switching to electronic nicotine delivery systems (ENDS) versus using nicotine replacement therapy (NRT) to promote abstinence from cigarettes. The project...
This federal Project Grant award, provided by the National Institutes of Health (NIH) under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), will fund a randomized controlled trial to assess the effectiveness of nicotine pouches as a cigarette substitute. The $773,359 grant, awarded to the University of Wisconsin - Madison on September 1, 2024, will support the enrollment of 284 adult daily smokers in a 4-week study to compare the use of 3-mg...
The National Cancer Institute (NCI) awarded a Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) in the amount of $661,139 to The Ohio State University to conduct a 6-year study on the use of oral nicotine pouches (ONPs) as a substitute for cigarette smoking among rural Appalachian adults. The study will randomize 1,000 adult smokers in rural Appalachia to either an ONP or nicotine replacement therapy (NRT) arm, with participants sampling products during a 2-week phase and...
This $594,099 Project Grant awarded by the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) to Brown University will characterize behavioral and cognitive mechanisms underlying dual use of marijuana and tobacco in young adults. The project will employ novel laboratory-based measures, including a cross-price elasticity of demand task and cross-cue reactivity assessment, to understand how demand and craving for these substances interact. The research aims to provide...